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Affinity chromatography ofplasminogen and its proteoIytic fragments on immobilized fibrinogen TSD frag- 
ment has shown that the latter contains a plasminogen-binding site which is complementary to the lysine- 
binding site(s) of plasminogen molecule l-3 kringle structures. 
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1. INTRODUCTION 
The main biological function of plasmin is the 
lysis of fibrin clots. Specific binding of the plasmin 
precursor (plasminogen) and its activator to fibrin 
is the basis of the molecular mechanism of 
fibrinolysis. Fibrin considerably stimulates the ac- 
tivation of plasminogen into plasmin as well as 
protecting the latter from inactivation by in- 
hibitors. At present the localization of 
plasminogen-binding sites on fibrin is under active 
investigation [l-5]. Nevertheless, the mechanism 
of interaction of plasminogen with fibrin remains 
unclear. 
Convenient objects for studying different types 
of interaction between these proteins are their pro- 
teolytic fragments. These fragments retain struc- 
tural and functional properties which are inherent 
to the entire molecule. Fibrinogen E fragment, 
originating from the central part of the molecule, 
was shown to contain a Lys-plasminogen-binding 
site. Therefore the central fibrin domain was sup- 
posed to be the site of plasminogen binding ]2,3]. 
It has recently been demonstrated that fibrinogen 
fragment D is also able to bind to Lys-plasminogen 
[2]. On the other hand, there are some data sug- 
gesting that fibrinogen D fragment does not 
possess piasminogen-binding properties [1,5]. This 
discrepancy may be accounted for by the non- 
identical character of the fibrinogen fragment D 
preparations tudied by different authors since it is 
known that the properties of the D fragment, in 
particular its anti-coagulation activity, are strongly 
dependent on the method of preparation [6,7]. 
Early DI or Du fragments (MI 95 000) are split 
from the terminal parts of the fibrinogen molecule 
during restricted proteolysis [7,8]. A further pro- 
teolysis of DI or Du fragments in the absence of 
Ca2+ results in splitting of the C-terminal part of 
the y-chain and formation of the so-called ‘light’ 
D fragment (DL) or Dnnr~ with an Mr of 82OOO 
[f&9]. It has been shown that the association cons- 
tant of the light fragment DEDTA with Lys- 
plasminogen-Sepharose is about 1 l-fold higher 
than that of fragment Dr 141. Using special condi- 
tions it is possible to isolate the thermostable 
region of the DL fragment as the TSD fragment 
with an Mr of 28 000 [lo]. This fragment has a 
compact structure of the coiled-coil type as well as 
the terminal parts of the E fragment [lo, 1 I]. This 
structure has been shown to be necessary for re- 
taining the plasminogen-binding site on fragment 
E [4]. Supposing structural homology of the 
pIasminogen-binding sites of fibrinogen fragments 
D and E we can expect the plasminogen-binding 
site of the Dr. fragment to be situated on its ther- 
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mostable part. Therefore we studied the interac- 
tion of the TSD fragment of fibrinogen with 
plasminogen and its proteolytic fragments. The 
results obtained show that the TSD fragment of 
fibrinogen contains a plasminogen-binding site 
which is complementary to the lysine-binding site 
of plasminogen molecule l-3 kringle structures. 
2, MATERIALS AND METHODS 
Human Lys-plasminogen was obtained by the 
method in f12]. Minipi~minogen, Kt-3 and K4 
fragments were prepared by elastolysis of Lys- 
plasminogen as described in [13,14], Plasmin 
heavy (A) and light (B) chains were prepared by 
selective reduction of its interchain disulphide links 
as in [IS]. All these preparations retained their 
functional activity: Lys-plasminogen and miniplas- 
minogen were able to be activated with strep- 
tokinase to plasmin and miniplasmin, respectively, 
and plasmin light chain in combination with strep- 
tokinase was able to form the activation complex 
[16]. The heavy chain of plasmin as well as the 
Kl-3 and K4 fragments possessed lysi~e-binding 
properties. Dn and DL fragments were prepared by 
the method described in [g] from bovine fibrinogen 
isolated according to 1171. The TSD fragment was 
prepared by pepsin hydrolysis of the Dn fragment 
[ 101. Purity of the obtained preparations was 
checked by SDS electrophoresis in 7.5% 
polyacrylamide gel as in [18]. Fig. 1 shows that 
none of the employed preparations contained 
perceptible impurities. 
The TSD fragment as well as the Dt fragment 
were immobilized on CNBr-activated Sepharose. 
The concentration of the immobilized protein was 
determined using three different ways: (i) the 
method of Lowry et al. [19]; (ii) amino acid 
analysis of immobilized protein after 24 h 
hydrolysis in 6 M NC1 at 105°C; (iii) calculation of 
the difference between the amount of imm~bili2ed 
protein and that of unbound protein. The concen- 
tration of the immobi~~ed TSD fragment was 20 
FM. Immobilized DL fra~ent was prepared at the 
same concentration. The interaction of the im- 
mobilized TSD fragment with plasminogen and its 
derivatives was studied by affinity chromatog- 
raphy. Protein in 100 mM sodium phasphate, pH 
7.4, was applied to a column of 5 ml volume. Un- 
bound protein was washed out by the same buffer. 
Then specifically sorbed protein was eluted with a 
3 mM solution of e-aminocaproic acid (e-ACA). 
All experiments on affinity binding of protein were 
performed at 20°C. 
3. RESULTS AND DISCUSSIONS 
Fig.2 presents an elution profile of plasminogen 
from the immobilized TSD fragment. It is obvious 
that plasminogen possesses a strong selective af- 
finity for the-immobilized TSD fragment which 
G 
m 
* 
Fig. 1. ~~~-~l~a~r~la~id~ gef electraphoretie patterns 
of fibrinogen DL (1) and TSD (2) fragments, Lys- 
plasminogen f3), ~~ni~~~s~nogen (4), plasminogen 
&agments RI-3 and K4 (5 and 6, respectively) and 
plasmin heavy (7) and light (8) chains. 
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Pig.2 Lys-pIasm~nogen affinity chromatography on 
immobilized TSR fragment. The arrow indicates efution 
with 3 mM r-ACA. 
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demonstrates the presence of plasminogen-binding 
sites in its structure. The results from the affinity 
chromatography were quantitatively analyzed. Us- 
ing immobilized TSD fragment we were able to 
determine equilibrium concentrations of Lys- 
plasminogen both bound and unbound with TSD 
fragment. It was determined that the time 
necessary to establish equilibrium did not exceed 5 
min and thus the protein applied to the column was 
exposed for about 10 min. Unbound protein was 
rapidly eluted by 100 mM phosphate buffer to 
detect the equilibrium concentration of free ligand 
in the incubation mixture. The concentration of 
the complex was determined from the amount of 
protein specifically bound to the affinity column. 
Specifically bound plasminogen presents a fraction 
eluted by 3 mM +ACA. Fig.3a shows that the 
quantity of bound plasminogen increases with the 
amount of protein applied to the column and 
reaches saturation asymptotically approaching a 
maximal value. This dependence is a typical ad- 
sorption isotherm for affinity chromatography 
[20], which permits presentation of the obtained 
results on Scatchard coordinates and determina- 
tion of the dissociation constant and quantity of 
binding centres for Lys-plasminogen. Fig.3b 
reveals that the apparent dissociation constant 
amounts to 0.44 PM and that there is one 
plasminogen-binding site in each molecule of the 
TSD fragment. The interaction of the immobilized 
Dr fragment with Lys-plasminogen was also 
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Fig.3.(a) Isotherm of affinity sorption of Lys- 
plasminogen on the immobilized TSD fragment. Pgapp 
and pgb, applied and bound Lys-plasminogen, 
respectively. (b) Scatchard plot for the specific binding 
of Lys-plasminogen to TSD fragment. [TSD], [Pgb] and 
[Pgr], the molar concentration of the TSD fragment, 
specifically bound and free Lys-plasminogen, 
respectively. 
studied using this method. We found that there is 
one site in the structure of the Dr. fragment for 
binding Lys-plasminogen with a dissociation cons- 
tant of 0.43 PM which in fact equals the dissocia- 
tion constant of the complex formed between im- 
mobilized TSD fragment and Lys-plasminogen. 
Thus, it can be concluded that the plasminogen- 
binding site of Dr fragment is located in its ther- 
mostable part. The low and equal values of the 
dissociation constants provide evidence of the high 
affinity of the interacting molecules and of preser- 
vation of binding site structure during 
immobilization. 
Fig.2 shows that all plasminogen bound to the 
affinity column was completely eluted by E-ACA. 
Subsequent elution with 100 mM L-arginine 
revealed no protein in the eluate. It follows that the 
immobilized TSD fragment interacts with Lys- 
plasminogen via the lysine-binding site(s) of the 
latter. Benzamidine-binding sites of plasminogen, 
which have been localized in miniplasminogen and 
the plasmin light chain [21], are apparently exclud- 
ed from this interaction. Varadi and Patthy [4] 
have found that the E fragment plasminogen- 
binding site is located in its coiled-coil region. As 
fragment D also carries a large region of the coiled- 
coil connector rod, they supposed that structural 
homology between plasminogen-binding sites of 
the E and D fragments was possible. Since the TSD 
fragment includes a coiled-coil region of the D 
fragment, our data strongly support their 
assumption. 
To localize on the plasminogen molecule the 
binding sites complementary to that of the TSD 
fragment we have studied the sorption of 
miniplasminogen, Kl-3, K4 fragments, and 
plasmin heavy and light chains on the immobilized 
TSD fragment. Fig.4a shows that miniplasmino- 
gen and plasmin light chain were not bound by the 
affinity column, because both were completely 
eluted by 100 mM phosphate buffer. At the same 
time the plasmin heavy chain consisting of 5 
kringle structures (Kl-5) is specifically sorbed on 
the immobilized TSD fragment and completely 
eluted by e-ACA (fig.4b). Thus one may conclude 
that the interaction of Lys-plasminogen with the 
TSD fragment is mediated by lysine-binding sites 
localized in the heavy chain region. Kl-3 and K4 
fragments are parts of the plasmin heavy chain and 
both contain lysine-binding sites [22], however, 
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Fig.4. Afrmity cbrornato~a~h~ of (a) rn~~~p~~~~~~g~ 
f - ) and @asmin fight chain ( - - ), fb) plasm~n heavy 
chain C---f and U-3 fragment i f - -) on the 
immobilized ‘IX3 fragment of fibrinogen. EIution with 
3 mM +ACA is indicated by the arrow. 
K1-3 is bound by the immobilized TSD fragment 
whereas K4 is not. Therefore, the iysine-binding 
site(s) of the Lys-plasminogen molecuIe, which is 
fare) com~~~rne~tary to the binding site on the 
TSD fragment, is (are) 0~ its 1-3 krfngte s~~ct~res 
and differ s~r~ct~ra~~y from the 4 kringie binding 
site. 
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